Biotech

Israeli biotech Clearmind Medicine appoints ex-Red Bull executive special advisor for development of MEAI as an alcohol substitute

Israeli biotech Clearmind Medicine appoints ex-Red Bull executive special advisor for development of MEAI as an alcohol substitute

Clearmind Medicine Inc. Nicholas Kadysh, a former Red Bull Canada and Juul Labs Canada executiveis an expert in regulatory issues VANCOUVER, 09 Dec. 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“clear mind“or the”vsinsult“), a biotechnology company focused on the discovery and development of novel psychedelic-derived therapies to address major …

Israeli biotech Clearmind Medicine appoints ex-Red Bull executive special advisor for development of MEAI as an alcohol substitute Read More »

3 biotech actions to reinvent mental health treatment

3 biotech actions to reinvent mental health treatment

Mental health issues are a growing concern in the United States. According to the National Institute of Mental Health (NIMH), almost 20% of adults, or 43 million people, suffer from some form of mental illness each year. Conditions can range from mild states like depression and anxiety to more serious conditions like dementia, bipolar disorder, …

3 biotech actions to reinvent mental health treatment Read More »

Intrinsic Medicine and Phoenix Biotech Acquisition Corp.  mutually agree to terminate the business combination agreement

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement

SEATTLE, 06 Dec. 12, 2022 (GLOBE NEWSWIRE) — Intrinsic Medicine, Inc. (Intrinsic), a therapeutic company leveraging breast milk biology to transform gut-brain axis (GBA) and inflammatory disorders, and Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (PBAX), a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with …

Intrinsic Medicine and Phoenix Biotech Acquisition Corp. mutually agree to terminate the business combination agreement Read More »